Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 8,629 | 12,818 | 7,804 | 28,243 | 10,216 |
| Operating Income | -8,629 | -12,818 | -7,804 | -6,381 | -10,216 |
| Other Income | 237 | 307 | 384 | 509 | 261 |
| Pre-tax Income | -8,392 | -12,511 | -7,420 | -5,872 | -9,955 |
| Net Income Continuous | -8,392 | -12,511 | -7,420 | -5,872 | -9,955 |
| Net Income | $-8,392 | $-12,511 | $-7,420 | $-5,872 | $-9,955 |
| EPS Basic Total Ops | -4.54 | -6.78 | -4.03 | 0.15 | -6.57 |
| EPS Basic Continuous Ops | -4.54 | -6.78 | -4.03 | 0.25 | -6.57 |
| EPS Diluted Total Ops | -4.54 | -6.78 | -4.03 | 0.15 | -6.57 |
| EPS Diluted Continuous Ops | -4.54 | -6.78 | -4.03 | 0.25 | -6.57 |
| EPS Diluted Before Non-Recurring Items | -4.54 | -6.75 | -4.00 | N/A | N/A |
| EBITDA(a) | $-8,610 | $-12,819 | $-7,795 | $-28,098 | $-10,331 |